Clinically significant or uncontrolled cardiac disease.
Serious co-morbid medical conditions, including clinically-significant cardiac disease
History of clinically significant cardiac dysfunction
Clinically significant cardiac disease.
History of clinically significant cardiac dysfunction
History of clinically significant cardiac disease; uncontrolled hypertension
Clinically significant cardiac disease
History of clinically significant cardiac or pulmonary dysfunction as specified in antecedent study
History of clinically significant cardiac dysfunction
History of autoimmune disease, clinically significant cardiac or pulmonary dysfunction
Clinically significant cardiac disease.
Clinically significant, uncontrolled heart disease and/or recent cardiac event (within 6 months prior to randomization)
Active or clinically significant cardiac disease.
History of clinically significant or uncontrolled cardiac disease including but not limited to:
History of clinically significant cardiac dysfunction
Patients must not have clinically significant cardiac disease.
Clinically significant cardiac disease
Documented clinically significant cardiac arrhythmias
Have a significant cardiac condition.
Active or clinically significant cardiac disease
clinically significant cardiac disease
Subjects with clinically significant uncontrolled cardiac disease
Clinically significant cardiac disease
History or current diagnosis of cardiac disease indicating significant risk of safety for patients participating in the study such as uncontrolled or significant cardiac disease
Clinically significant or uncontrolled cardiac disease.
Clinically significant cardiac disease
History of clinically significant cardiac disease
Clinically significant cardiac disease as per protocol-defined criteria.
Have clinically significant cardiac disease
Sustained or clinically significant cardiac arrhythmias
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality, or clinically significant cardiac arrhythmias
Significant history or risk of cardiac disease
Has clinically significant cardiac disease
History of clinically significant or uncontrolled cardiac, hepatic, or pulmonary disease
Significant active cardiac disease within the previous 6 months
Has clinically significant cardiac disease
Clinically significant cardiac disease
Clinically significant cardiac disease
Clinically significant cardiac or pulmonary dysfunction
Significant active cardiac disease within the previous 6 months, including:
Clinically significant, uncontrolled heart disease and/or recent cardiac repolarization abnormality including any of the following:
Clinically significant active cardiac disease, uncontrolled heart disease and/or history of cardiac dysfunction including any of the following
Clinically significant (i.e. active) cardiac disease (e.g. symptomatic coronary artery disease, uncontrolled cardiac arrhythmia, or myocardial infarction within the last 6 months); any history of clinically significant cardiac failure
Active or clinically significant cardiac disease including:
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality
Uncontrolled or significant cardiac disease
Clinically significant or uncontrolled hypertension or cardiac disease
Have clinically significant cardiac disease
History of clinically significant cardiac or pulmonary dysfunction
Clinically significant, uncontrolled heart disease and/or recent cardiac event within 6 months prior to study
No clinically significant cardiac conduction disorder on screening.
History of clinically significant or uncontrolled cardiac disease.
Significant cardiac impairment
Significant cardiac disease within 6 months
Clinically significant cardiac disease as defined in the protocol
Clinically significant cardiac disease
Significant cardiac disease
Evidence or history of significant cardiac disease
Clinically significant cardiac disease
Significant cardiac events
History of clinically significant cardiac disease
Clinically significant, uncontrolled heart disease and/or recent cardiac events.
Clinically significant cardiac disease
History of clinically significant cardiac dysfunction
Clinically significant cardiac disease, including:
Have clinically significant cardiac disease
Clinically significant cardiac disease
Uncontrolled systemic disease (e.g., clinically significant cardiac, pulmonary or metabolic disease)
Significant history of cardiac disease
History of clinically significant cardiac disease.
Significant history of cardiac disease
Clinically significant cardiac disease;
Clinically significant cardiac or pulmonary dysfunction
Significant active cardiac disease within the previous 6 months:
Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality, or clinically significant cardiac arrhythmias
History of clinically significant cardiac or pulmonary dysfunction
Sustained or clinically significant cardiac arrhythmias
Any clinically significant comorbidities, such as uncontrolled pulmonary disease, known impaired cardiac function or clinically significant cardiac disease (specified below), active CNS disease, active infection, or any other condition that could compromise the participant's participation in the study.
Clinically significant cardiac disease
Subjects with clinically significant uncontrolled cardiac disease
Clinically significant cardiac or pulmonary disease
Significant active cardiac disease within the previous 6 months, including:
History of clinically significant or uncontrolled cardiac disease.
Clinically significant cardiac disease within last 12 months
History of clinically significant or active cardiac disease
Clinically significant, uncontrolled heart disease and/or recent cardiac event (within 6 months
History of clinically significant cardiac dysfunction